Two of the best stop smoking medications have been available in the UK since 2024 – so why is no one using them?

By Jonathan Livingstone-Banks, Lecturer & Senior Researcher in Evidence-Based Healthcare, University of Oxford
Dimitra Kale, Senior Research Fellow, Health Psychology, UCL
Lion Shahab, Professor in Health Psychology, UCL

In 2021, varenicline, the most effective single drug for quitting smoking, was withdrawn from the market in the UK because impurities were found at greater levels than is considered safe.

Rapidly, varenicline (then sold under its brand names, Champix and Chantix) became unavailable. This was a disaster for public health. Research from University…

Read complete article

~	Healing through music: Defying silence in Myanmar

~	Australia’s supercomputers are falling behind – and it’s hurting our ability to adapt to climate change

~	What do stingrays actually eat? New study reveals some only prefer a single type of prawn

~	Gen Z is burning out at work more than any other generation — here’s why and what can be done

~	What can trees teach us about resilience and loss? A grieving daughter reflects

~	NZ needs more entrepreneurs. Will its new tertiary strategy reward real risk takers?

~	Putting away your winter clothes? Science explains how to keep them safe over summer

~	Illegal tobacco is messing up economic data. That won’t stop until it’s managed like alcohol

~	How important is the ATAR? 30% of Year 12s who go to uni don’t use it

~	Hospitals in crisis: why state and federal governments are fighting about funding